Abstract Hypertension is a major modifiable risk factor for cardiovascular disease (CVD) which is a leading cause of death in developing countries affecting both genders. Gender dissimilarity in clinical characteristics and hypertension (HTN) management among hypertensive patients has been reported in several reports before. The aim was to detect sex differences in clinical characteristics and HTN management among Egyptian hypertensive patients. Data from 4701 hypertensive patients attending 9 university located Specialized Hypertension clinic (SHC) were collected from October 2014 to September 2017. The collected data included demographics, cardiovascular risk profile, hypertension‐related history, anthropometric and blood pressure (BP) me...
Hypertension is a major risk factor for cardiovascular disease and outcomes in women, and antihypert...
In industrialized countries, cardiovascu-lar disease (CVD) is the leading cause of death in women as...
Bangladesh is facing an epidemiological transition with a growing burden of non-communicable disease...
Background: Gender consideration is not factored into guidelines for management of hypertension. We ...
International audienceThe objective of our study was to investigate differences in the management of...
OBJECTIVE: To summarize all available literature on sex differences in the pharmacological treatment...
OBJECTIVE: To describe and explain sex differences in antihypertensive drug use. DESIGN AND METHODS:...
There is strong evidence that sex chromosomes and sex hormones influence blood pressure (BP) regulat...
BACKGROUND: To evaluate potential sex differences, this study aimed to investigate blood pressure an...
SummaryBackgroundSeveral studies have shown gender differences in the management of cardiovascular r...
Cardiovascular death represents the single largest cause of mortality in women with 70% of deaths at...
The prevalence of hypertension in Malaysia is alarmingly high. The National Survey in 2006 showed 43...
In European countries and in the USA, hypertension represents an important risk factor for cardiovas...
Hypertension is a major risk factor for cardiovascular disease and outcomes in women, and antihypert...
There is strong evidence that sex chromosomes and sex hormones influence blood pressure (BP) regulat...
Hypertension is a major risk factor for cardiovascular disease and outcomes in women, and antihypert...
In industrialized countries, cardiovascu-lar disease (CVD) is the leading cause of death in women as...
Bangladesh is facing an epidemiological transition with a growing burden of non-communicable disease...
Background: Gender consideration is not factored into guidelines for management of hypertension. We ...
International audienceThe objective of our study was to investigate differences in the management of...
OBJECTIVE: To summarize all available literature on sex differences in the pharmacological treatment...
OBJECTIVE: To describe and explain sex differences in antihypertensive drug use. DESIGN AND METHODS:...
There is strong evidence that sex chromosomes and sex hormones influence blood pressure (BP) regulat...
BACKGROUND: To evaluate potential sex differences, this study aimed to investigate blood pressure an...
SummaryBackgroundSeveral studies have shown gender differences in the management of cardiovascular r...
Cardiovascular death represents the single largest cause of mortality in women with 70% of deaths at...
The prevalence of hypertension in Malaysia is alarmingly high. The National Survey in 2006 showed 43...
In European countries and in the USA, hypertension represents an important risk factor for cardiovas...
Hypertension is a major risk factor for cardiovascular disease and outcomes in women, and antihypert...
There is strong evidence that sex chromosomes and sex hormones influence blood pressure (BP) regulat...
Hypertension is a major risk factor for cardiovascular disease and outcomes in women, and antihypert...
In industrialized countries, cardiovascu-lar disease (CVD) is the leading cause of death in women as...
Bangladesh is facing an epidemiological transition with a growing burden of non-communicable disease...